[4,4ꢀ-bpy-N-(CH2)10OC6H3-3,5-tBu2]Cl ([1a]Cl).
A
DMF
C6H3), 8.49 (2H, C10H8N2), 8.95–9.08 (4H, C10H8N2). The low
(20 mL) solution containing 4,4ꢀ-bipyridine (1.6 g, 10 mmol) a◦nd
Cl(CH2)10OC6H3-3,5-tBu2 (1.9 g, 5.0 mmol) was stirred at 100 C
for 22 h. Evaporation of the solvent gave an orange oil which was
washed with Et2O and toluene. Recrystallization from CH2Cl2–
solubility of complexes prevented 13C{ H} NMR measurement.
1
IR (KBr disk, r.t.): mmax/cm−1 2924, 1140 (S O), 1024, 442 (PtS).
=
UV absorption kmax(CHCl3)/nm 249 (e/dm3 mol−1 cm−1 18500).
[trans-2b][PtCl3(dmso)]. To a solution of K[PtCl3(dmso)]
(164 mg, 0.39 mmol) in H2O (4 mL) was adde◦d an aqueous solution
(2 mL) of [1b]Cl (45 mg, 0.18 mmol) at 0 C. The solid formed
immediately was collected by filtration and washed with EtOH
and Et2O. The crude product was purified by recrystallization
from MeNO2–Et2O, washed with EtOH and Et2O and dried under
reduced pressure to give [trans-2b][PtCl3(dmso)] as a white solid
1
Et2O yielded [1a]Cl as a white solid (1.5 g, 2.8 mmol, 55%). H
NMR (300 MHz, dmso-d6, r.t.): d 1.24 (s, 18H, CH3), 1.24–1.44
(12H, CH2), 1.67 (m, 2H, OCH2CH2), 1.94 (m, 2H, NCH2CH2),
3.91 (t, 2H, OCH2, J(HH) = 6 Hz), 4.64 (t, 2H, NCH2, J(HH) =
7 Hz), 6.67 (s, 2H, ortho-C6H3), 6.93 (s, 1H, para-C6H3), 8.04 (d,
2H, C10H8N2, J(HH) = 6 Hz), 8.63 (d, 2H, C10H8N2, J(HH) = 6
Hz), 8.86 (d, 2H, C10H8N2, J(HH) = 6 Hz), 9.23 (d, 2H, C10H8N2,
1
(116 mg, 0.12 mmol, 67%). H NMR (300 MHz, CD3NO2, r.t.):
1
J(HH) = 6 Hz). 13C{ H} NMR (75.5 MHz, dmso-d6, r.t.): d 25.4
d 1.00 (t, 3H, CH3, J(HH) = 8 Hz), 1.48 (m, 2H, CH2), 2.13 (m,
2H, CH2), 3.28 (s, 6H, CH3, J(PtH) = 22 Hz), 3.44 (s, 6H, CH3),
4.77 (t, 2H, CH2, J(HH) = 8 Hz), 8.07 (m, 2H, C10H8N2), 8.49 (d,
2H, C10H8N2, J(HH) = 7 Hz), 8.97 (m, 2H, C10H8N2), 8.99 (d, 2H,
(CH2), 25.6 (CH2), 28.4 (CH2), 28.8 (2C, CH2), 28.9 (2C, CH2),
30.8 (CH2), 31.2 (CH3), 34.6 (CCH3), 60.3 (NCH2), 67.0 (OCH2),
108.6 (ortho-C6H3), 114.0 (para-C6H3), 122.0 (C10H8N2), 125.4
(C10H8N2), 140.9 (C10H8N2), 145.4 (C10H8N2), 151.0 (C10H8N2),
151.6 (C10H8N2), 152.2 (meta-C6H3), 158.3 (ipso-C6H3). Calc.
for C34H49N2ClO·3H2O: C, 69.07; H, 9.38; N, 4.74; Cl, 6.00.
Found: C, 68.98; H, 9.09; N, 4.70; Cl, 6.37%. ESIMS: Calc. for
C34H49N2O: 501.4. Found: m/z = 501.8 [M − Cl]+. UV absorption
kmax(H2O)/nm 261 (e/dm3 mol−1 cm−1 17600).
1
C10H8N2, J(HH) = 7 Hz). 13C{ H} NMR (75.5 MHz, CD3NO2,
r.t.): d 13.8 (CH2CH3), 20.4 (CH2), 34.3 (CH2), 44.1 (SCH3), 44.4
(SCH3), 125.7 (C10H8N2), 128.1 (C10H8N2), 146.5 (C10H8N2), 154.2
(C10H8N2). The signal of the NCH2 carbon was overlapped with
the signal of CD2HNO2 (d 62.8). Calc. for C18H29N2Cl5O2Pt2S2:
C, 23.07; H, 3.12; N, 2.99; S, 6.84; Cl, 18.92. Found: C, 23.02; H,
3.04; N, 3.03; S, 6.70; Cl, 19.14%. IR (KBr disk, r.t.): mmax/cm−1
[4,4ꢀ-bpy-N-nBu]Cl ([1b]Cl). A toluene (20 mL) solution con-
taining 4,4ꢀ-bipyridine (2.5 g, 16 mmol) and nBuCl (12.5 ml,
60 mmol) was refluxed for 96 h. The solid formed by the reaction
was collected by filtration and washed with toluene to give [1b]Cl
=
2917, 1134 (S O), 1022, 442 (PtS).
[2]Pseudorotaxane ([3a]Cl). To a solution of [1a]Cl (2.4 mg,
4.4 × 10−3 mmol) in dmso-d6–D2O (1.2 mL–0.4 mL) was added
a-CD (42.8 mg, 4.4 × 10−2 mmol). A part of the solution was
transferred into an NMR tube and1H NMR spectra were recorded
periodically. The solution contained [1a]Cl and [3a]Cl. 1H NMR
data of [3a]Cl (300 MHz, dmso-d6–D2O (3 : 1), r.t.): d 1.18–1.42
(12H, CH2-axis), 1.21 (s, 18H, CH3), 1.46–1.66 (2H, OCH2CH2),
1.84–2.06 (2H, NCH2CH2), 3.16–3.80 (36H, CH-a-CD), 3.86*
(2H, OCH2), 3.92–4.36 (6H, CH-a-CD), 4.46–4.64 (2H, NCH2),
6.58 (s, 2H, ortho-C6H3), 6.92 (s, 1H, para-C6H3), 7.92 (2H,
C10H8N2), 8.36–8.44 (2H, C10H8N2), 8.74–8.80 (2H, C10H8N2), 9.03
(d, 2H, C10H8N2, J(HH) = 7 Hz). The peak with an asterisk was
overlapped significantly with the signal of the solvent. ESIMS:
Calc. for C70H109N2O31: 1473.7. Found: m/z = 1473.8 [M − Cl]+.
1
as a white solid (468 mg, 1.9 mmol, 12%). H NMR (300 MHz,
dmso-d6, r.t.): d 0.92 (t, 3H, CH3, J(HH) =8 Hz), 1.32 (m, 2H,
CH2), 1.93 (m, 2H, CH2), 4.65 (t, 3H, NCH2, J(HH) = 8 Hz),
8.04 (d, 2H, C5H4N, J(HH) = 6 Hz), 8.64 (d, 2H, C10H8N2,
J(HH) = 6 Hz), 8.86 (d, 2H, C10H8N2, J(HH) = 6 Hz), 9.25 (d,
1
2H, C10H8N2, J(HH) = 6 Hz). 13C{ H} NMR (100 MHz, dmso-
d6, r.t.): d 13.3 (CH3), 18.7 (CH2), 32.7 (CH2), 60.0 (NCH2), 121.8
(C10H8N2), 125.2 (C10H8N2), 140.8 (C10H8N2), 145.3 (C10H8N2),
150.8 (C10H8N2), 151.8 (C10H8N2). Calc. for C14H17N2Cl·0.25H2O:
C, 66.40; H, 6.96; N, 11.06; Cl, 14.00. Found: C, 66.60; H, 7.08;
N, 11.03; Cl, 14.08%. ESIMS: Calc. for C14H17N2: 213.1. Found:
m/z = 213.5 [M − Cl]+.
[trans-2a][PtCl3(dmso)]/[cis-2a][PtCl3(dmso)]. To a solution
of K[PtCl3(dmso)] (200 mg, 0.48 mmol) in H2O (2 mL) was added
an aqueous solution (4.0 mL) of [1a]Cl (60 mg, 0.12 mmol) at
Reaction of a-CD with [1b]Cl). [1b]Cl (10 mg, 0.04 mmol) and
a-CD (39 mg, 0.04 mmol) were charged to an NMR tube. After
addition of D2O (0.7 mL) to the mixture, the 1H NMR spectrum
showed almost exactly the signals of [1b]Cl.
0
◦C. The solution was stirred for 3 min and the solid formed
was collected by filtration, washed with water and dried under
reduced pressure to give a mixture of [trans-2a][PtCl3(dmso)]/[cis-
2a][PtCl3(dmso)] (= 6 : 1) as a yellow solid (95 mg, 0.077 mmol,
67%). Calc. for C38H61N2Cl5O3Pt2S2: C, 37.24; H, 5.02; N, 2.29;
S, 5.23; Cl, 14.47. Found: C, 37.53; H, 5.07; N, 2.33; S, 5.00; Cl,
14.84%.
1H NMR data of [trans-2a][PtCl3(dmso)] (300 MHz, CD3NO2,
r.t.): d 8.06 (d, 2H, J(HH) = 7 Hz). 1H NMR data of [cis-
2a][PtCl3(dmso)] (300 MHz, CD3NO2, r.t.): d 7.99 (d, 2H,
J(HH) = 7 Hz). Other signals of [trans-2a][PtCl3(dmso)] and
[cis-2a][PtCl3(dmso)] were not distinguished from each other
due to severe overlapping; d 1.30 (s, 18H, C(CH3)3), 1.30–1.44
(12H, CH2), 1.76 (m, 2H, OCH2CH2), 2.16 (m, 2H, NCH2CH2),
3.28 (s, 6H, PtCl3{SO(CH3)2}, J(PtH) = 22 Hz), 3.44 (br, 6H,
PtCl2{SO(CH3)2}), 4.00 (t, 2H, OCH2, J(HH) = 7 Hz), 4.77 (t, 2H,
NCH2, J(HH) = 7 Hz), 6.78 (s, 2H, ortho-C6H3), 7.10 (s, 1H, para-
[trans-4a][PtCl3(dmso)]. To a solution of K[PtCl3(dmso)]
(126 mg, 0.30 mmol) in H2O (6 mL) was added a solution of
[1a]Cl (80 mg, 0.15 mmol) and a-CD (584 mg, 0.60 mmol) in H2O
(12 mL) at 0 ◦C to cause immediate separation of a colorless solid
which was collected by filtration. The crude product was washed
with cold water and dried in vacuo to give [trans-4a][PtCl3(dmso)]
(167 mg, 0.076 mmol, 53%). 1H NMR (300 MHz, D2O, r.t.):
d 1.13 (s, 18H, CCH3), 1.29–1.34 (br, 12H, CH2), 1.46 (br, 2H,
OCH2CH2), 1.98 (br, 2H, NCH2CH2), 3.34–3.74 (m, 36H, CH,
CH2), 3.40 (s, 12H, SCH3), 3.83 (br, 2H, OCH2), 4.89 (s, 6H,
CH-a-CD), 6.67 (s, 2H, ortho-C6H3), 7.04 (s, 1H, para-C6H3),
7.91 (d, 2H, C10H8N2, J(HH) = 7 Hz), 8.28 (d, 2H, C10H8N2,
J(HH) = 6 Hz), 8.74 (d, 2H, C10H8N2, J(HH) = 6 Hz), 8.88
(d, 2H, C10H8N2, J(HH) = 6 Hz). The low solubility of [trans-
1
4a][PtCl3(dmso)] in D2O prevents 13C{ H} NMR measurement.
5350 | Dalton Trans., 2006, 5345–5351
This journal is
The Royal Society of Chemistry 2006
©